Similar articles

• Clinical strategies for breast cancer screening: weighing and using the evidence.

  Harris R, Leininger L. Harris R, et al. Ann Intern Med. 1995 Apr 1;122(7):539-47. doi: 10.7326/0003-4819-122-7-199504010-00011. Ann Intern Med. 1995. PMID: 7872591 Review.
• Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.

  Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, Trentham-Dietz A, Munoz D, Lee SJ, Berry DA, van Ravesteyn NT, Alagoz O, Kerlikowske K, Tosteson AN, Near AM, Hoeffken A, Chang Y, Heijnsdijk EA, Chisholm G, Huang X, Huang H, Ergun MA, Gangnon R, Sprague BL, Plevritis S, Feuer E, de Koning HJ, Cronin KA. Mandelblatt JS, et al. Ann Intern Med. 2016 Feb 16;164(4):215-25. doi: 10.7326/M15-1536. Epub 2016 Jan 12. Ann Intern Med. 2016. PMID: 26756606 Free PMC article.
• Mammography screening. Benefits, harms, and informed choice.

  Jørgensen KJ. Jørgensen KJ. Dan Med J. 2013 Apr;60(4):B4614. Dan Med J. 2013. PMID: 23651722 Review.
• Time-Related Changes in Yield and Harms of Screening Breast Magnetic Resonance Imaging.

  Pederson HJ, O'Rourke C, Lyons J, Patrick RJ, Crowe JP Jr, Grobmyer SR. Pederson HJ, et al. Clin Breast Cancer. 2015 Oct;15(5):348-52. doi: 10.1016/j.clbc.2015.01.006. Epub 2015 Jan 21. Clin Breast Cancer. 2015. PMID: 25749071
• The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.

  Broeders M, Paci E. Broeders M, et al. Womens Health (Lond). 2015 Nov;11(6):883-90. doi: 10.2217/whe.15.34. Epub 2015 Nov 30. Womens Health (Lond). 2015. PMID: 26619214